Income statement
USD
Annual
| Metric | 2012 | 2011 | 2010 | 2008 | 2007 |
|---|---|---|---|---|---|
| Revenue | 8M | 5M | 6M | 0 | 0 |
| Gross Profit | 1M | 1M | 2M | 0 | 0 |
| Operating Income | -3M | -4M | -7M | 17K | 8K |
| EBITDA | -80K | -4M | -5M | -17K | 8K |
| Net Income | -435K | 2M | -12M | -17K | -8K |
| EPS (Diluted) | — | — | — | — | — |
Consumer Defensive
Live Price
Offline$0.0002
+0.00% today
1Y Change
-99.33%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zurvita Holdings, Inc. (ZRVT) is a Consumer Defensive stock with listed on OTC. The stock last traded around $0.00 and down 99.3% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +70.5%, EPS growth of -213.7%, a dividend yield of 0.0%. What stands out right now is revenue +70.5%, EPS -213.7%, free cash flow +37.1% with operating margin -35.4% and ROIC 702.7%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZRVT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZRVT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZRVT Max Drawdown
-99.33%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ZRVT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$7.8K
+53.6% YoY
Free Cash Flow
-$7.8K
+49.1% YoY
Revenue Growth
+70.5%
EPS Growth
-213.7%
Gross Margin
17.5%
Net Margin
-5.5%
Income statement
USD
| Metric | 2012 | 2011 | 2010 | 2008 | 2007 |
|---|---|---|---|---|---|
| Revenue | 8M | 5M | 6M | 0 | 0 |
| Gross Profit | 1M | 1M | 2M | 0 | 0 |
| Operating Income | -3M | -4M | -7M | 17K | 8K |
| EBITDA | -80K | -4M | -5M | -17K | 8K |
| Net Income | -435K | 2M | -12M | -17K | -8K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|
| Cash & Equivalents | 239K | 906 | 289K | 1M | 14K |
| Total Assets | 951K | 404K | 3M | 4M | 14K |
| Total Liabilities | 11M | 10M | 15M | 4M | 2K |
| Shareholder Equity | -10M | -10M | -12M | -876K | 13K |
| Total Debt | 858K | 3M | 2M | 2M | 0 |
| Net Debt | 619K | 3M | 2M | 231K | -14K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
8K
+49.1% YoY
Capital Expenditures
0
Free Cash Flow
8K
+49.1% YoY
Key ratios
Gross Margin
17.5%
Operating Margin
-35.4%
Net Margin
-5.5%
ROE
4.4%
Debt / Equity
-0.08x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.